Table 2 Characteristics of non MDR and and MDR-TB patients, healthcare utilization, and cost (standard errors in parentheses), Latvia 2002
MDR-TB (n=9) | Non MDR-TB (n=54) | p-value | |
|---|---|---|---|
Vital status, % | |||
Dead | 6.6 | 3.7 | .461 |
Alive | 93.4 | 96.3 | .461 |
Age, years | 44.1 (1.3) | 42.6 (2.5) | .558 |
Age group, % | |||
<25 | 6.6 | 14.8 | .105 |
25-64 | 89.0 | 74.1 | .019 |
65 or over | 4.4 | 11.1 | .123 |
Sex, % | |||
Male | 78.0 | 63.0 | .050 |
Female | 22.0 | 37.0 | .050 |
Treatment success, % | |||
Cured | 71.4 | 90.7 | .006 |
Not cured | 28.6 | 9.3 | .006 |
Previous treatment, # (%) | |||
None | 31 (33%) | 54 (100%) | <.001 |
First-line | 55 (60%) | 0 | <.001 |
Second-line | 6 (7%) | 0 | <.001 |
Hospital days, # | 481.4 (25.0) | 114.9 (12.6) | <.001 |
Clinic visits, # | 73.7 (13.4) | 70.4 (9.2) | .859 |
Specialist visits, # | 11.0 (1.3) | 5.1 (.6) | <.001 |
Sputum smears, # | 35.9 (1.3) | 12.9 (.7) | <.001 |
Sputum cultures,# | 33.9 (1.4) | 10.4 (.6) | <.001 |
X-rays, # | 14.1 (.8) | 6.4 (.5) | <.001 |
CT, # | 1.0 (.1) | .5 (.1) | .011 |
Health care costs, 2002 USD $ | |||
Inpatient | $25,004 (1,301) | $6,904 (759) | <.001 |
Outpatient | $1,672 (303) | $1,443 (188) | .587 |
Prescription medication | $2,146 (115) | $601 (3) | <.001 |
Total treatment | $28,821 (1,245) | $8,408 (649) | <.001 |